SEC Form 3 · accession 0001354488-15-002876
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard L Wang
Officer — Chief Operating Officer
Period of report
May 24, 2015
Accepted (ET)
Jun 5, 2015 · 6:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share | holding | — | — | — | 500 | D |
Table II — derivative securities
No Table II lines on this filing.